ClinicalTrials.gov
ClinicalTrials.gov Menu

Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01227811
Recruitment Status : Unknown
Verified October 2010 by Center for Clinical Pharmacology Research Bdbeq S.A..
Recruitment status was:  Not yet recruiting
First Posted : October 25, 2010
Last Update Posted : October 25, 2010
Sponsor:
Collaborator:
Laboratorio Elea S.A.C.I.F. y A.
Information provided by:
Center for Clinical Pharmacology Research Bdbeq S.A.

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2010
  Estimated Study Completion Date : March 2011

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 July 14, 2011 August 8, 2011
2 August 9, 2011 September 9, 2011
3 September 11, 2011  
4 September 13, 2011 October 14, 2011
5 October 15, 2011 November 15, 2011
6 October 10, 2012 November 8, 2012
7 December 20, 2012 January 29, 2013
8 March 22, 2013 May 1, 2013
9 June 30, 2014 July 29, 2014